Effect of 1, 3-bis (2-phenyl-4-chromenon-5-yl)-2-ol on experimental asthma in guinea pigs.
D000284:Administration, Oral; D000818:Animals; D001249:Asthma / Q000188:drug therapy*; D004205:Cromolyn Sodium / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004195:Disease Models, Animal; D006168:Guinea Pigs; D008297:Male
C028875:1,3-bis(2-phenyl-4-chromenon-5-yl)propan-2-ol; D004205:Cromolyn Sodium